Fortress Biotech, Inc. (FBIO) vs Rein Therapeutics Inc. (RNTX)
Fortress Biotech, Inc. and Rein Therapeutics Inc. are both Biotechnology companies. Fortress Biotech, Inc. and Rein Therapeutics Inc. are of similar size ($76.0M and $73.8M). Rein Therapeutics Inc. has negative trailing earnings, so its P/E is not meaningful; Fortress Biotech, Inc. trades at 0.7×. Fortress Biotech, Inc. has the higher net margin (151.0% vs 0.00%) and the lower return on invested capital (−41.3% vs 0.00%). Across the 14 metrics below, Fortress Biotech, Inc. leads on 9 and Rein Therapeutics Inc. on 5.
Valuation
Profitability
| Metric | FBIO | RNTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 65.59% | 0.00% | 65.16% |
| Operating margin | (42.61%) | 0.00% | 0.00% |
| Net margin | 150.98% | 0.00% | 0.00% |
| Free cash flow margin | 183.80% | 0.00% | 0.00% |
| Return on equity | 84.91% | (753.55%) | (57.72%) |
| Return on assets | 43.38% | (80.62%) | (49.22%) |
| Return on invested capital | (41.34%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack